NXTS — Nexentis Technologies Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1789192 ·
Last close
$1.82
Market Cap
$2.65M
52W High
$119.00
52W Low
$1.80
ADV30
169,081
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -1,735,000 -11,145,000 18,692,000 7,623,000 16,910,000
Mar 2026 0 — -2,277,000 -6,580,000 16,399,000 4,299,000 3,538,000
Dec 2025 -68,000 — -587,000 1,269,000 20,405,000 3,832,000 4,675,000
Sep 2025 2,000 0 -1,326,000 429,000 11,026,000 6,044,000 2,350,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,429,000
Investing CF
$-2,168,000
Financing CF
$11,068,000
CapEx
$-835,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-59.19
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-56,282,000
Inventory
$16,000
Receivables
$509,000
ST Investments
$1,257,000
EBIT TTM
$-9,737,000
Pretax Income TTM
$-16,434,000
Interest Exp TTM
$10,889,000
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -5,366,000 -4,004,000 20,400,000 4,675,000 16,010,000 -3,808,000
Dec 2024 0 -3,283,000 -5,193,000 5,465,000 892,000 4,749,000 -3,419,000
Dec 2023 263,000 -7,537,000 -6,522,000 7,244,000 786,000 6,480,000 -3,234,000
Dec 2022 394,004 -5,819,642 -5,739,600 6,492,213 754,872 5,846,379 -5,097,126
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$-29,735,000
NetIncome TTM
$-16,027,000
OpCashFlow TTM
—
Assets (Latest)
$18,692,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
ERNA Ernexa Therapeutics Inc. $2.66M $1.63 —
BIXT BIOXYTRAN, INC $2.66M $0.02 —
MBIO MUSTANG BIO, INC. $2.63M $0.39 —
EOCN EoCene Ltd. $2.63M $2.46 —
PPBT PURPLE BIOTECH LTD. $2.78M $1.71 —

News headlines (Yahoo Finance, 1h cache)

Nexentis: MitoCareX Progresses Toward In-Vitro Evaluation Following AI-Powered Computational Screening
2026-11-17 13:03 · Yahoo
Nexentis Announces Reverse Stock Split
2026-11-05 14:00 · Yahoo
Nexentis: MitoCareX Completes Initial AI-Powered Computational Screening Milestone with Boltz
2026-10-29 11:22 · Yahoo
Nexentis: MitoCareX Bio Advances AI-Driven Drug Discovery Initiative with Boltz, Completing Initial Computational Screening Stage
2026-10-26 12:16 · Yahoo
Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
2026-10-12 12:07 · Yahoo
Nexentis Deploys MitoCareX Computational Drug Discovery Infrastructure on Google Cloud
2026-10-07 14:03 · Yahoo
Nexentis: MitoCareX Bio Deploys its Computational Drug Discovery Infrastructure on Google Cloud
2026-10-07 11:32 · Yahoo
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
2026-09-24 11:50 · Yahoo
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
2026-09-23 11:07 · Yahoo
Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS)
2026-06-29 14:10 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.